← FDA DRUG APPROVALS

FDA ANDA · ANDA075704

FAMOTIDINE

Sponsor: RISING

APPLICATION
ANDA075704
TYPE
ANDA
ORIGINAL APPROVAL
2001-04-16
LATEST ACTION
2020-05-13
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

FAMOTIDINEPrescription
FAMOTIDINE 20MG · TABLET · ORAL
FAMOTIDINEPrescription
FAMOTIDINE 40MG · TABLET · ORAL

Approval history

2020-05-13Labeling · Supplement 19 · standardAP
2020-05-13Labeling · Supplement 18 · standardAP
2016-05-16Labeling · Supplement 16 · standardAP
2013-06-27Labeling · Supplement 15 · standardAP
2003-05-14Labeling · Supplement 3AP
2001-04-16OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →